119 related articles for article (PubMed ID: 22228163)
1. Risk factors for rectal stump cancer in inflammatory bowel disease.
Lutgens MW; van Oijen MG; Vleggaar FP; Siersema PD; Broekman MM; Oldenburg B;
Dis Colon Rectum; 2012 Feb; 55(2):191-6. PubMed ID: 22228163
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
3. Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
Ten Hove JR; Bogaerts JMK; Bak MTJ; Laclé MM; Meij V; Derikx LAAP; Hoentjen F; Mahmmod N; van Tuyl SA; Oldenburg B
Inflamm Bowel Dis; 2019 Jan; 25(2):377-384. PubMed ID: 30085111
[TBL] [Abstract][Full Text] [Related]
4. [Adenocarcinoma in a closed rectal stump in inflammatory bowel disease].
Petersen CN; Raahave D
Ugeskr Laeger; 2008 Oct; 170(41):3251. PubMed ID: 18940161
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
Lian L; Menon KV; Shen B; Remzi F; Kiran RP
Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.
Bergeron V; Vienne A; Sokol H; Seksik P; Nion-Larmurier I; Ruskone-Fourmestraux A; Svrcek M; Beaugerie L; Cosnes J
Am J Gastroenterol; 2010 Nov; 105(11):2405-11. PubMed ID: 20551939
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
9. Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study.
Boldovjakova D; El-Abbassy I; Alarcon I; El-Saify M; Chan JH; Harley M; Parnaby C; Watson A; Ramsay G
Dig Dis; 2023; 41(6):872-878. PubMed ID: 37690444
[TBL] [Abstract][Full Text] [Related]
10. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
[TBL] [Abstract][Full Text] [Related]
11. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
13. High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the Amsterdam criteria.
Cirillo L; Urso ED; Parrinello G; Pucciarelli S; Moneghini D; Agostini M; Nitti D; Nascimbeni R
Ann Surg; 2013 May; 257(5):900-4. PubMed ID: 22968081
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
15. Dehydration is the most common indication for readmission after diverting ileostomy creation.
Messaris E; Sehgal R; Deiling S; Koltun WA; Stewart D; McKenna K; Poritz LS
Dis Colon Rectum; 2012 Feb; 55(2):175-80. PubMed ID: 22228161
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
18. [Emergency surgery in inflammatory bowel disease. Experience in 26 cases].
D'Addazio G; Scordamaglia R; Tedeschi U; Barra M; Arpe F; Beatini L; Meola V
Minerva Chir; 1998 Dec; 53(12):1001-7. PubMed ID: 10210930
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.
Haanstra JF; de Vos Tot Nederveen Cappel WH; Gopie JP; Vecht J; Vanhoutvin SA; Cats A; van der Zaag-Loonen HJ; Langers AM; Bergmann JH; van de Meeberg PC; Dekker E; Kleibeuker JH; Vasen HF; Nagengast FM; van Duijvendijk P
Dis Colon Rectum; 2012 Jun; 55(6):653-9. PubMed ID: 22595844
[TBL] [Abstract][Full Text] [Related]
20. Short article: Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel disease.
Derikx LAAP; de Jong ME; Hoentjen F
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):843-846. PubMed ID: 29781837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
